Zobrazeno 1 - 10
of 77
pro vyhledávání: '"neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales [ENFERMEDADES]"'
Autor:
Javier Ros, Francesc Salva, Cristina Dopazo, Daniel López, Nadia Saoudi, Iosune Baraibar, Ramon Charco, Josep Tabernero, Elena Elez
Publikováno v:
Scientia
Liver transplantation; Metastatic colorectal cancer Trasplantament de fetge; Càncer colorectal metastàtic Trasplante de hígado; Cáncer colorrectal metastásico Colorectal cancer (CRC) is a prevalent disease worldwide, with more than 50% of patien
Autor:
Josep Tabernero, Eric Van Cutsem, Elena Garralda, David Tai, Filippo De Braud, Ravit Geva, Mark T J van Bussel, Katia Fiorella Dotti, Elena Elez, María J de Miguel, Kevin Litwiler, Danielle Murphy, Michelle Edwards, Van Karlyle Morris
Publikováno v:
Scientia
Background WNT974 is a small molecule inhibitor of Wnt signaling that specifically inhibits porcupine O-acyltransferase. This phase Ib dose-escalation study evaluated the maximum tolerated dose of WNT974 in combination with encorafenib and cetuxima
Autor:
Stefania Napolitano, Melanie Woods, Hey Min Lee, Vincenzo De Falco, Giulia Martini, Carminia Maria Della Corte, Erika Martinelli, Vincenzo Famiglietti, Davide Ciardiello, Amanda Anderson, Natalie Wall Fowlkes, Oscar Eduardo Villareal, Alexey Sorokin, Preeti Kanikarla, Olu Coker, Van Morris, Lucia Altucci, Josep Tabernero, Teresa Troiani, Fortunato Ciardiello, Scott Kopetz
Publikováno v:
Scientia
Purpose: Encorafenib + cetuximab (E+C) is an effective therapeutic option in chemorefractory BRAFV600E metastatic colorectal cancer (mCRC). However, there is a need to improve the efficacy of this molecular-targeted therapy and evaluate regimens suit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206f53de24b61dea932f3c6f45b9c5eb
https://hdl.handle.net/11351/9975
https://hdl.handle.net/11351/9975
Autor:
Yoshino, Takayuki, Di Bartolomeo, Maria, Raghav, Kanwal, Masuishi, Toshiki, Loupakis, Fotios, Kawakami, Hisato, Elez, Elena
Publikováno v:
Scientia
Colorectal cancer; Metastasis; Targeted therapies Cáncer colorrectal; Metástasis; Terapias dirigidas Càncer de colorectal; Metàstasi; Teràpies dirigides DESTINY-CRC01 (NCT03384940) was a multicenter, open-label, phase 2 trial assessing the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::8b6d5dc04fa6fd2cffb00515c05e07f8
https://hdl.handle.net/11351/9735
https://hdl.handle.net/11351/9735
Autor:
E. Van Cutsem, I. Danielewicz, M. P. Saunders, P. Pfeiffer, G. Argilés, C. Borg, R. Glynne-Jones, C. J. A. Punt, A. J. Van de Wouw, M. Fedyanin, D. Stroyakovskiy, H. Kroening, P. Garcia-Alfonso, H. Wasan, A. Falcone, R. Fougeray, A. Egorov, N. Amellal, V. Moiseyenko
Publikováno v:
British journal of cancer, 126(11), 1548-1554. Nature Publishing Group
Scientia
Scientia
Background Therapeutic options are limited in patients with unresectable metastatic colorectal cancer (mCRC) ineligible for intensive chemotherapy. The use of trifluridine/tipiracil plus bevacizumab (TT-B) in this setting was evaluated in the TASCO1
Autor:
Martinelli, Erika, Arnold, Dirk, Cervantes, Andrés, Stintzing, Sebastian, Van Cutsem, Eric, Tabernero Caturla, Josep
Publikováno v:
Scientia
Consensus; Metastatic colorectal cancer; Treatment Consens; Càncer colorectal metastàtic; Tractament Consenso; Cáncer colorrectal metastásico; Tratamiento Metastatic colorectal cancer (mCRC) is a heterogenous disease caused by various genetic alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::2050f58da1bbc03410c1f0a1080051ed
https://hdl.handle.net/11351/9258
https://hdl.handle.net/11351/9258
Autor:
Ros Montañá, Fco. Javier, Balconi, Francesca, Baraibar Argota, Iosune, Salva Ballabrera, Francesc, Tabernero Caturla, Josep, Elez Fernandez, Mª Elena, Saoudi Gonzalez, Nadia
Publikováno v:
Scientia
Colorectal cancer; Microsatellite stable; Tyrosine kinase inhibitors Cáncer colorrectal; Microsatélite estable; Inhibidores de la tirosina cinasa Càncer colorectal; Microsatèl·lit estable; Inhibidors de la tirosina cinasa Immune checkpoint inhib
Autor:
J. Ros, J. Matito, G. Villacampa, R. Comas, A. Garcia, G. Martini, I. Baraibar, N. Saoudi, F. Salvà, Á. Martin, M. Antista, R. Toledo, E. Martinelli, F. Pietrantonio, A. Boccaccino, C. Cremolini, R. Dientsmann, J. Tabernero, A. Vivancos, E. Elez
Publikováno v:
Scientia
BRAF inhibitor; Colorectal cancer Inhibidor de BRAF; Cáncer colorrectal Inhibidor de BRAF; Càncer colorectal Background Combination of a BRAF inhibitor (BRAFi) and an anti-epidermal growth factor receptor (EGFR), with or without a MEK inhibitor (ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f87297706728a50806cc4c43925d9eb
https://hdl.handle.net/11591/499335
https://hdl.handle.net/11591/499335
Autor:
Michel Ducreux, Josep Tabernero, Axel Grothey, Dirk Arnold, Peter J. O'Dwyer, Frank Gilberg, Alexander Abbas, Meghna Das Thakur, Hen Prizant, Natsumi Irahara, Anila Tahiri, Hans-Joachim Schmoll, Eric Van Cutsem, Aimery de Gramont
Publikováno v:
Scientia
Biomarkers; Colorectal cancer; Maintenance therapy Biomarcadors; Càncer colorectal; Teràpia de manteniment Biomarcadores; Cáncer colorrectal; Terapia de mantenimiento Purpose MODUL is an adaptable, signal-seeking trial of biomarker-driven maintena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1928ff25405d828ae1ca88ab540d68af
Autor:
Ian Y. Luk, Laura J. Jenkins, Kael L. Schoffer, Irvin Ng, Janson W. T. Tse, Dmitri Mouradov, Stanislaw Kaczmarczyk, Rebecca Nightingale, Allan D. Burrows, Robin L. Anderson, Diego Arango, Higinio Dopeso, Larry Croft, Mark F. Richardson, Oliver M. Sieber, Yang Liao, Jennifer K. Mooi, Natalia Vukelic, Camilla M. Reehorst, Shoukat Afshar-Sterle, Vicki L. J. Whitehall, Lochlan Fennell, Helen E. Abud, Niall C. Tebbutt, Wayne A. Phillips, David S. Williams, Wei Shi, Lisa A. Mielke, Matthias Ernst, Amardeep S. Dhillon, Nicholas J. Clemons, John M. Mariadason
Publikováno v:
Scientia
Epigenetics; Tumour-suppressor proteins Epigenética; Proteínas supresoras de tumores Epigenètica; Proteïnes supresores de tumors Colorectal cancers (CRCs) often display histological features indicative of aberrant differentiation but the molecula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c1771def1a2b343893e5c103bb2bd76